On Wednesday, Shares of Bristol-Myers Squibb Co (NYSE:BMY), subtract -0.07% and closed at $54.79 in the last trading session. The last trading range of the stock ranges between $54.49 and $55.20. The company’s Market capitalization is $92.47 Billion with the total Outstanding Shares of 1.66 Billion. Bristol-Myers Squibb Company (BMY) recently declared new data across eight tumor types evaluating Opdivo (nivolumab) and Yervoy (ipilimumab), as monotherapy or in combination, in addition to new assets, to be presented at the 2016 European Society for Medical Oncology (ESMO) Congress in Copenhagen, Denmark from October 7–11. Data presented at this congress underscore the Company’s commitment to its portfolio and to discover the next wave of transformational Immuno-Oncology medicines, counting combination therapies, for difficult-to-treat cancers.
“Bristol-Myers Squibb continues to lead the scientific understanding of Immuno-Oncology with an extensive portfolio and a differentiated clinical development program where we have set a high bar of success to look for clear and differentiated improvements over presently available therapies,” said Fouad Namouni, M.D., head of development, Oncology, Bristol-Myers Squibb. “We remain focused on expanding the use of the Opdivo and Yervoy combination to more tumors, and bringing forward novel agents and combination regimens in earlier lines of therapy, to assist even more patients with cancer.”
Bristol-Myers Squibb assets featured in a total of 26 data presentations. A select listing of Presidential Symposia and oral abstract sessions is included below:
CheckMate -064: Baseline tumor T cell receptor sequencing analysis and neo-antigen load is associated with response and survival in melanoma patients receiving sequential Opdivo and Yervoy (Abstract #1047O). Data will be presented during an oral proferred paper session on Friday, October 7 at 4:45 – 5:00 p.m. CEST.
CheckMate -275: First disclosure of efficacy and safety of Opdivo monotherapy in patients with metastatic urothelial cancer who have received prior treatment (Abstract #LBA31_PR). Data will be presented during an oral proffered paper session on Saturday, October 8 at 9:15 – 9:30 a.m. CEST.
Axion Power International, Inc. (OTCMKTS:AXPW), dropped -21.69% and closed at $0.00650 in the last trading session. The last trading range of the stock ranges between $0.01 and $0.01. The company’s Market capitalization is $255.278.00 with the total Outstanding Shares of 39.27 million. Last week, Axion Power International, Inc. (AXPW) CEO, Richard Bogan, and vice president of engineering, Jack Shindle, were interviewed on National Public Radio, 90.5 WESA Pittsburgh, discussing the capabilities and usefulness of Axion’s PbC® technology.
The interview and resulting article, New Castle Company Working to Make an Old Technology New Again, are available. The article outlines the potential of PbC technology to “revolutionize the lead acid battery industry.” Among its features, PbC offers quick recharge, the ability to operate in a partial state of charge, a longer cycle life and is nearly 100 percent recyclable.
Shindle and Bogan are referenced explaining the difference between PbC batteries and standard lead acid batteries. “The challenge with the traditional lead acid battery is that the battery never gets a chance to fully recharge and ends up operating in partial state of charge,” began Shindle. “Lead acid batteries are made of a series of negatively and positively charged lead plates.”
Speaking about PbC batteries, Bogan continues, “Instead of a negative lead plate, it uses an activated carbon plate which assists the battery better perform with a partial state of charge.”
SUPERVALU INC. (NYSE:SVU), gained 2.43% and closed at $5.05 in the last trading session. The last trading range of the stock ranges between $4.94 and $5.07. During the 52-week trading session the minimum price at which share price traded, registered at $3.94 and reached to max level of $7.84. SUPERVALU INC., together with its auxiliaries, operates as a grocery wholesaler and retailer in the United States. The company operates through three segments: Wholesale, Save-A-Lot, and Retail. The Wholesale segment offers wholesale distribution of various food and non-food products to independent retail customers, such as single and multiple grocery store independent operators, regional chains, and the military. This segment operates about 1,796 stores with a network spanning 40 states. The Save-A-Lot segment owns, operates, and licenses 1,360 discount grocery stores under the Save-A-Lot banner, counting 897 licensed Save-A-Lot stores and 463 company-operated stores. The Retail segment operates retail stores that provide groceries and various additional products, counting general merchandise, home, health and beauty care, and pharmacy products. This segment operates 200 stores under the Cub Foods, Shoppers Food & Pharmacy, Shop n Save, Farm Fresh, and Hornbachers banners, in addition to 2 Rainbow and 2 County Market stores.